The Scientist

» leukemia

Most Recent

image: CT Scans Increase Risk of Cancer

CT Scans Increase Risk of Cancer

By | June 7, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

1 Comment

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

0 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

15 Comments

image: Telomeres in Disease

Telomeres in Disease

By | May 1, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

16 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

48 Comments

image: Turning T-cells into Cancer Killers

Turning T-cells into Cancer Killers

By | August 10, 2011

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

21 Comments

image: Stem Cells Hit Reverse

Stem Cells Hit Reverse

By | July 31, 2011

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

0 Comments

image: Interfering with Cancer

Interfering with Cancer

By | January 1, 2011

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech